Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/31230
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.date.accessioned | 2023-02-28T07:20:26Z | - |
dc.date.available | 2023-02-28T07:20:26Z | - |
dc.date.issued | 2007-01-18 | - |
dc.identifier.citation | Akçağlar, S. vd. (2006). "Two cases of cryptococcal meningitis in immunocompromised patients not infected with HIV". Mycoses, 50(3), 235-238. | en_US |
dc.identifier.issn | 0933-7407 | - |
dc.identifier.issn | 1439-0507 | - |
dc.identifier.uri | https://doi.org/10.1111/j.1439-0507.2006.01347.x | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/j.1439-0507.2006.01347.x | - |
dc.identifier.uri | http://hdl.handle.net/11452/31230 | - |
dc.description | Bu çalışma, 17-20 Haziran 2014 tarihlerinde Krakow[Polonya]'da düzenlenen 10. Congress of the European Confederation of Medical Mycology'da bildiri olarak sunulmuştur. | tr_TR |
dc.description.abstract | We present the cases of two patients with cryptococcal meningitis who were predisposed to fungal infection because of diabetes mellitus (Case 1) and systemic lupus erythematosus (Case 2). Both patients were tested negative for anti-HIV antibodies. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Dermatology | en_US |
dc.subject | Mycology | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Cerebrospinal fluid | en_US |
dc.subject.mesh | Cryptococcus neoformans | en_US |
dc.subject.mesh | Diabetes complications | en_US |
dc.subject.mesh | Fatal outcome | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Hiv seronegativity | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunocompromised host | en_US |
dc.subject.mesh | Lupus erythematosus, systemic | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Meningitis, cryptococcal | en_US |
dc.title | Two cases of cryptococcal meningitis in immunocompromised patients not infected with HIV | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000246151400015 | tr_TR |
dc.identifier.scopus | 2-s2.0-34247630126 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji ve Enfeksiyon Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-4803-8206 | tr_TR |
dc.contributor.orcid | 0000-0002-4759-9634 | tr_TR |
dc.identifier.startpage | 235 | tr_TR |
dc.identifier.endpage | 238 | tr_TR |
dc.identifier.volume | 50 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Mycoses | en_US |
dc.contributor.buuauthor | Akçağlar, Sevim | - |
dc.contributor.buuauthor | Sevgican, Emine | - |
dc.contributor.buuauthor | Akalın, Halis | - |
dc.contributor.buuauthor | Ener, Beyza | - |
dc.contributor.buuauthor | Töre, Okan | - |
dc.contributor.researcherid | AAU-8952-2020 | tr_TR |
dc.contributor.researcherid | AAG-8523-2021 | tr_TR |
dc.identifier.pubmed | 17472624 | tr_TR |
dc.subject.wos | Dermatology | en_US |
dc.subject.wos | Mycology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 6506194958 | tr_TR |
dc.contributor.scopusid | 16246450600 | tr_TR |
dc.contributor.scopusid | 57207553671 | tr_TR |
dc.contributor.scopusid | 15053025300 | tr_TR |
dc.contributor.scopusid | 6505909596 | tr_TR |
dc.subject.scopus | Cryptococcosis; Immunocompromised Patient; Fluconazole | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Cerebrospinal fluid | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Cryptococcal meningitis | en_US |
dc.subject.emtree | Diabetes mellitus | en_US |
dc.subject.emtree | Disease course | en_US |
dc.subject.emtree | Disease predisposition | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Fungus culture | en_US |
dc.subject.emtree | Hospital admission | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human immunodeficiency virus | en_US |
dc.subject.emtree | Immunoassay | en_US |
dc.subject.emtree | Immunocompromised patient | en_US |
dc.subject.emtree | Laboratory test | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mycosis | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Systemic lupus erythematosus | en_US |
dc.subject.emtree | Treatment response | en_US |
dc.subject.emtree | Amphotericin b | en_US |
dc.subject.emtree | Amphotericin b lipid complex | en_US |
dc.subject.emtree | Antifungal agent | en_US |
dc.subject.emtree | Corticosteroid | en_US |
dc.subject.emtree | Fluconazole | en_US |
dc.subject.emtree | HLA antibody | en_US |
dc.subject.emtree | Prednisolone | en_US |
Koleksiyonlarda Görünür: | PubMed Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.